A detailed history of Kesler, Norman & Wride, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Kesler, Norman & Wride, LLC holds 4,014 shares of LLY stock, worth $3.2 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
4,014
Previous 3,642 10.21%
Holding current value
$3.2 Million
Previous $3.3 Million 7.86%
% of portfolio
0.71%
Previous 0.71%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$772.14 - $960.02 $287,236 - $357,127
372 Added 10.21%
4,014 $3.56 Million
Q2 2024

Jul 23, 2024

BUY
$724.87 - $909.04 $476,239 - $597,239
657 Added 22.01%
3,642 $3.3 Million
Q1 2024

Apr 19, 2024

BUY
$592.2 - $792.28 $1.34 Million - $1.79 Million
2,263 Added 313.43%
2,985 $2.32 Million
Q4 2023

Jan 10, 2024

BUY
$525.19 - $619.13 $379,187 - $447,011
722 New
722 $420,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $757B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Kesler, Norman & Wride, LLC Portfolio

Follow Kesler, Norman & Wride, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kesler, Norman & Wride, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kesler, Norman & Wride, LLC with notifications on news.